Biopsy Analysis
Microscopic evaluation of tissue samples to confirm malignancy. The foundational step in every cancer diagnosis pathway.
Accurate cancer diagnosis through advanced laboratory science — reliable, timely, and precise cancer identification at the cellular level.

The Foundation of Cancer Diagnosis
The Department of Onco Pathology plays a foundational role in cancer care. Accurate diagnosis begins in the laboratory — and our pathology services ensure reliable, timely, and precise cancer identification through microscopic and molecular examination of tissues, blood, and body fluids.
Pathology reports are integrated into every Multidisciplinary Tumor Board discussion at MIO Hospital, ensuring treatment decisions are backed by precise diagnostic evidence.
Comprehensive pathology services covering the full spectrum of cancer diagnosis
Microscopic evaluation of tissue samples to confirm malignancy. The foundational step in every cancer diagnosis pathway.
Detailed study of tumor architecture and grading — providing critical information about cancer type and aggressiveness.
Analysis of cells obtained from body fluids or fine-needle aspiration (FNAC). Rapid, minimally invasive diagnostic method.
Identifies tumor markers and receptor status — essential for guiding targeted therapy decisions and prognosis.
Supports personalized and precision oncology treatment decisions based on tumor's genetic and molecular profile.
Correct pathological diagnosis is the cornerstone of effective cancer treatment. Our laboratory findings directly determine:

Specialists with deep expertise in cancer pathology and tumor marker analysis.
Rigorous laboratory quality assurance ensuring accuracy and reproducibility of results.
Timely pathology reports to support prompt clinical decision-making without delay.
Comprehensive biomarker testing for personalized treatment planning and precision oncology.
Routine biopsy reports are typically available within 5–7 working days. Urgent cases and intraoperative frozen sections are expedited. Your team will inform you of the timeline.
IHC identifies specific proteins in cancer cells, helping determine the cancer subtype, hormone receptor status, and eligibility for targeted therapies like Herceptin in breast cancer.
Yes. We offer expert second opinion pathology review services for patients who have received a diagnosis elsewhere and wish to have it confirmed at MIO Hospital.
If you require biopsy evaluation or a second opinion pathology review, our expert team is here to help guide your cancer care journey.